Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Rheumatology 1, 8 (1 November 2005) | doi:10.1038/ncprheum0006
A new treatment strategy for severe refractory rheumatoid arthritis
Abstract
Teng YKO et al. (2005) Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 52: 2272–2276 High-dose chemotherapy (HDC) followed by autologous hematopoietic stem-cell transplantation (HSCT) is a new treatment strategy for patients with severe rheumatoid arthritis (RA) that is refractory to drug treatment.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
